BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koller D, Belmonte C, Lubomirov R, Saiz-rodríguez M, Zubiaur P, Román M, Ochoa D, Carcas A, Wojnicz A, Abad-santos F. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. J Psychopharmacol 2018;32:1212-22. [DOI: 10.1177/0269881118798605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Madsen HØ, Ba-Ali S, Heegaard S, Hageman I, Knorr U, Lund-Andersen H, Martiny K, Kessing LV. Melanopsin-mediated pupillary responses in bipolar disorder-a cross-sectional pupillometric investigation. Int J Bipolar Disord 2021;9:7. [PMID: 33644827 DOI: 10.1186/s40345-020-00211-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zubiaur P, Mejía-Abril G, Navares-Gómez M, Villapalos-García G, Soria-Chacartegui P, Saiz-Rodríguez M, Ochoa D, Abad-Santos F. PriME-PGx: La Princesa University Hospital Multidisciplinary Initiative for the Implementation of Pharmacogenetics. J Clin Med 2021;10:3772. [PMID: 34501219 DOI: 10.3390/jcm10173772] [Reference Citation Analysis]
3 Pinheiro HM, da Costa RM. Pupillary light reflex as a diagnostic aid from computational viewpoint: A systematic literature review. J Biomed Inform 2021;117:103757. [PMID: 33826949 DOI: 10.1016/j.jbi.2021.103757] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Koller D, Saiz-Rodríguez M, Zubiaur P, Ochoa D, Almenara S, Román M, Romero-Palacián D, de Miguel-Cáceres A, Martín S, Navares-Gómez M, Mejía G, Wojnicz A, Abad-Santos F. The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial. Br J Clin Pharmacol 2020;86:2051-62. [PMID: 32250470 DOI: 10.1111/bcp.14300] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Milosavljevic F, Bukvic N, Pavlovic Z, Miljevic C, Pešic V, Molden E, Ingelman-Sundberg M, Leucht S, Jukic MM. Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis. JAMA Psychiatry 2021;78:270-80. [PMID: 33237321 DOI: 10.1001/jamapsychiatry.2020.3643] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
6 Zubiaur P, Soria-Chacartegui P, Koller D, Navares-Gómez M, Ochoa D, Almenara S, Saiz-Rodríguez M, Mejía-Abril G, Villapalos-García G, Román M, Martín-Vílchez S, Abad-Santos F. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers. Biomed Pharmacother 2021;133:111087. [PMID: 33378980 DOI: 10.1016/j.biopha.2020.111087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Mcgovern JE, Reddy LF, Reavis EA, Green MF. Pupillary change on a cognitive effort task in schizophrenia: Associations with cognition and motivation. International Journal of Psychophysiology 2020;155:1-7. [DOI: 10.1016/j.ijpsycho.2020.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Soria-Chacartegui P, Villapalos-García G, Zubiaur P, Abad-Santos F, Koller D. Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone. Front Pharmacol 2021;12:711940. [PMID: 34335273 DOI: 10.3389/fphar.2021.711940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]